Clinical trials
Phase 1 Mouth Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 8 |
| Terminated | 6 |
| Active, not recruiting | 5 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| M.D. Anderson Cancer Center | 5 |
| Vanderbilt-Ingram Cancer Center | 3 |
| Roswell Park Cancer Institute | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Brian Henick, MD | 1 |
| Celldex Therapeutics | 1 |
| Emory University | 1 |
| Light Sciences LLC | 1 |
| Lumina Pharmaceuticals Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mouth Neoplasms | 33 |
| Head and Neck Neoplasms | 19 |
| Oropharyngeal Neoplasms | 14 |
| Laryngeal Neoplasms | 13 |
| Hypopharyngeal Neoplasms | 11 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Breast Neoplasms | 7 |
| Carcinoma, Squamous Cell | 6 |
| Carcinoma | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.